Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Addressing Racial Disparity Head-On
06/16/2021
This week, Dr Jennings discusses an example of an effective pharmacist-driven intervention focused on improving racial disparity in health care.
This week, Dr Jennings discusses an example of an effective pharmacist-driven intervention focused on improving racial disparity in health care.
This week, Dr Jennings discusses...
06/16/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Navigating the Omicron Hype: The Latest on Boosters
12/09/2021
Dr Jennings reviews recent data on the Omicron variant, highlighting what pharmacists should keep in mind when advising patients to receive booster shots.
Dr Jennings reviews recent data on the Omicron variant, highlighting what pharmacists should keep in mind when advising patients to receive booster shots.
Dr Jennings reviews recent data...
12/09/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Sparing Red Blood Cells During Cardiac Surgery
08/04/2022
In this week's issue of Talking Therapeutics, Dr Jennings weighs the potential risks and benefits of high- vs low-dose tranexamic acid for cardiac surgery.
In this week's issue of Talking Therapeutics, Dr Jennings weighs the potential risks and benefits of high- vs low-dose tranexamic acid for cardiac surgery.
In this week's issue of Talking...
08/04/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Cost Effectiveness of SGLT2 Inhibitors in Question for Patients With HFpEF
05/19/2023
Dr Jennings explores findings from a study in which researchers evaluated the cost effectiveness of SGLT2 inhibitors for patients with heart failure with preserved ejection fraction (HFpEF).
Dr Jennings explores findings from a study in which researchers evaluated the cost effectiveness of SGLT2 inhibitors for patients with heart failure with preserved ejection fraction (HFpEF).
Dr Jennings explores findings...
05/19/2023
Pharmacy Learning Network
Douglas Jennings
Talking Therapeutics
A Striking Win for Statins
05/24/2024
In this installment of Talking Therapeutics, Dr Jennings explores a new paper outlining the potential benefit of statins on key outcomes in patients with heart failure with preserved ejection fraction (HFpEF).
In this installment of Talking Therapeutics, Dr Jennings explores a new paper outlining the potential benefit of statins on key outcomes in patients with heart failure with preserved ejection fraction (HFpEF).
In this installment of Talking...
05/24/2024
Pharmacy Learning Network
Heart Failure Treatment Insight From ACC.2021
Talking Therapeutics
Heart Failure Treatment Insight From ACC.2021
05/19/2021
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of...
05/19/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Full Steam Ahead for SGLT2 Inhibitors
03/02/2022
In this week's Talking Therapeutics column, Dr Jennings reviews new data on SGLT2 inhibitors for patients with heart failure with preserved ejection fraction.
In this week's Talking Therapeutics column, Dr Jennings reviews new data on SGLT2 inhibitors for patients with heart failure with preserved ejection fraction.
In this week's Talking...
03/02/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
New Data Emerges for Managing Type 2 Diabetes
10/06/2022
Dr Jennings explores research comparing the efficacy of several SGLT2 inhibitors as second-line therapy options for patients with type 2 diabetes who have been treated with metformin.
Dr Jennings explores research comparing the efficacy of several SGLT2 inhibitors as second-line therapy options for patients with type 2 diabetes who have been treated with metformin.
Dr Jennings explores research...
10/06/2022
Pharmacy Learning Network
Talking Therapeutics
A New Breakthrough In Anticoagulation
09/26/2023
"Most patients with atrial fibrillation require life-long anticoagulation to prevent stroke, which exposes them to a significant cumulative risk for major hemorrhage, says Dr Jennings. "While most of the bleeding episodes that these patients...
"Most patients with atrial fibrillation require life-long anticoagulation to prevent stroke, which exposes them to a significant cumulative risk for major hemorrhage, says Dr Jennings. "While most of the bleeding episodes that these patients...
"Most patients with atrial...
09/26/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Confirming Tenecteplase Over Alteplase for Acute Ischemic Stroke
02/23/2023
Dr Jennings reviews new data comparing thrombolytic treatment options for patients with acute ischemic stroke.
Dr Jennings reviews new data comparing thrombolytic treatment options for patients with acute ischemic stroke.
Dr Jennings reviews new data...
02/23/2023
Pharmacy Learning Network

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use